Squarepoint’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$337K Sell
54,930
-141,890
-72% -$1.18M ﹤0.01% 3620
2025
Q4
$1.64M Buy
+196,820
New +$2.12M ﹤0.01% 2193
2025
Q2
Sell
-117,679
Closed -$671K 4608
2025
Q1
$671K Buy
117,679
+75,189
+177% +$766K ﹤0.01% 3022
2024
Q4
$417K Sell
42,490
-60,696
-59% -$520K ﹤0.01% 3894
2024
Q3
$841K Buy
103,186
+94,446
+1,081% +$946K ﹤0.01% 2734
2024
Q2
$117K Sell
8,740
-9,857
-53% -$294K ﹤0.01% 3767
2024
Q1
$863K Buy
18,597
+18,217
+4,794% +$943K ﹤0.01% 2697
2023
Q4
$25.7K Buy
+380
New +$23.3K ﹤0.01% 3902
2023
Q2
Sell
-36,377
Closed -$1.94M 3651
2023
Q1
$1.94M Buy
+36,377
New +$2.31M 0.01% 1433
2022
Q3
Sell
-2,297
Closed -$219K 3082
2022
Q2
$219K Buy
2,297
+696
+43% +$84.9K ﹤0.01% 2429
2022
Q1
$258K Buy
+1,601
New +$312K ﹤0.01% 2359

Other funds holding DNA